Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

Improving clinical outcomes among high risk Class III β thalassemia major patients (Class IIIHR) receiving an allogeneic SCT remains a challenge. From October, 2009 a treosulfan based regimen (TreoFluT) was used for all consecutive Class III patients (n = 50). The clinical outcomes were compared wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mathews, Vikram, George, Biju, Viswabandya, Auro, Abraham, Aby, Ahmed, Rayaz, Ganapule, Abhijeet, Sindhuvi, Eunice, Lakshmi, Kavitha M., Srivastava, Alok
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637210/
https://ncbi.nlm.nih.gov/pubmed/23637873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061637
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares